day one special courses - neurosurgery...day one special courses 7:00 am – 6:00 pm registration...

DAY ONE SPECIAL COURSES

7:00 AM – 6:00 PM

RegistrationGRAND BALLROOM FOYER – Fifth Floor

Noon - 5:00 PM

Speaker Ready RoomRAMPART - Fifth Floor

7:15 – 8:00 AM

Continental Breakfast for Special Course Participants

8:00 AM - Noon

Special Course 1 - Radiosurgery:Management of CV DiseaseMAUREPAS – Third Floor

Director: Bruce E. Pollock, MDPanelist: Michael Louis Schwartz, MD; Jason P. Sheehan,MD; Steven D. Chang, MD; Lawrence S. Chin, MD, FACS;David W. Andrews, MD; Antonio A. F. De Salles, MD, PhD

This course will provide an in-depth review of stereotacticradiosurgery as it relates to the management of patients witharteriovenous malformations, cavernous malformations anddural arteriovenous fistulas. At the completion of thiscourse, the participant will have an understanding of how radiosurgery can by applied in the treatment of these cerebrovascular diseases.

Learning Objectives: Upon completion of this specialcourse, attendees should be able to:

• Describe the basic technique and principles of radiosurgery.

• Discuss the role of radiosurgery for patients with arteriovenous malformations, cavernous malformations,and dural arteriovenous fistulas.

• Discuss the different methods that radiosurgery can beused to treat large arteriovenous malformations.

Special Course 2 - Management ofCervical Carotid and Vertebral ArteryAtherosclerosis GRAND COUTEAU – Fifth Floor

Co-Directors: John D. Barr, MD; Bohdan W.Chopko, MD, PhDPanelist: Avery J. Evans, MD; Robert E. Harbaugh, MD,FACS; Alex Abou-Chebl, MD

This special course will review the medical, surgical andendovascular treatment options for patients with cervicalcarotid and vertebral artery atherosclerotic stenosis. The natural history and risk of stroke will be discussed,

particularly with regard to patients with asymptomaticlesions. The risks and benefits of the various therapeuticoptions will be discussed, with emphasis on the recently FDA approved carotid artery stent systems.


• Discuss the risk of stroke from both symptomatic andasymptomatic stenoses of the carotid and vertebral arteries.

• Assess the different options for treating carotid and vertebral artery stenosis.

• Analyze the risks and benefits of carotid endarterectomy.

• Analyze the risks and benefits of carotid artery stenting.

Special Course 3 - Special Techniquesin Microsurgical Aneurysm Surgery -Rat Anastamosis DidacticThe bus will depart from the Canal Street entrance of the SheratonNew Orleans Hotel at 7:30 AM. This course will take place at theLSU Health Sciences Center, New Orleans.

Director: Saleem I. Abdulrauf, MDPanelists: Arthur L. Day, MD, FACS; Daniel L. Barrow, MD;H. Hunt Batjer, MD, FACS; Philip E. Stieg, PhD, MD; JacquesJ. Morcos, MD, FRCS; Fady T. Charbel, MD; Fredric B. Meyer,MD; Neil A. Martin, MD

The course is designed to review standard techniques forclipping anterior and posterior circulation aneurysms.Complex and giant aneurysmal reconstruction techniqueswill also be reviewed. Extra-Cranial to Intra-Cranial(EC-IC)bypass techniques for the treatment of giant aneurysms will be reviewed. Operative video will be used to illustratethese techniques.


• Discuss the various techniques of aneurysm clipping.

• Discuss the various techniques of giant aneurysm reconstruction.

• Analyze the indications and techniques of EC-IC bypass.

8:00 AM - 5:00 PM

Special Course 4 - Acute StrokeManagementBORGNE – Third Floor

C o - D i r e c t o r s : G a ry M. Nesbit, MD; Wade Smith, MD, PhDPanelists: J. Claude Hemphill III, MD, Randall T. Higashida,MD, Michael T. Lawton, MD, Gary Duckwiler, MD

16

17

This special course will discuss and review the logistical,medical, endovascular, and surgical management issues forpatient suffering from acute ischemic stroke. The natural history and currently approved clinical therapy for acutestroke will be reviewed along with potential new and tried andtrue therapy that have been developed or are under study.Logistical issues of setting up an acute stroke team, rapidtriage, and optimization of acute care under the "brain attack"concept will also be discussed.

Learning Objectives: Upon completion of this special course,attendees should be able to:

• Discuss the current indications and contraindications for using thrombolytic drugs in the treatment of acuteischemic stroke

• Describe the indications for endovascular embolectomy in acute ischemic stroke

• Discuss the main principles in medical management of ischemic stroke including blood pressure andantithrombotics

• Discuss the safety and efficacy of CT angiography in identifying large vessel stroke

• Discuss the value and potential limitations of perfusionimaging in selecting patients for revascularization therapy

• Describe how to apply for stroke center credentialing

• Discuss the role of procoagulant factors in treating hypertensive intracranial hemorrhage

• Describe the role for carotid endarterectomy and carotidstenting

1:00 - 5:00 PM

Special Course 5 - Management ofIntracranial Atherosclerotic DiseaseGRAND COUTEAU – Fifth Floor

C o - D i r e c t o r s : John D. Barr, MD; Bohdan W. Chopko, MD, PhDPanelist: Elad I. Levy, MD; Joan C. Wojak, MD; TakanoriFukushima, MD; Alex Abou-Chebl, MD

This special course will review the medical, surgical andendovascular treatment options for patients with intracranialarterial atherosclerotic stenosis. The natural history and risk of stroke will be discussed, particularly with regard topatients with asymptomatic lesions. The risks and benefits of the various therapeutic options will be discussed, withemphasis on intracranial angioplasty and stenting and external carotid-to-internal carotid artery bypass.


• Discuss the risk of stroke from both symptomatic andasymptomatic intracranial arterial stenosis.

• Assess the different options for treating intracranial arterial stenosis.

• Analyze the risks and benefits of and indications for surgical bypass.

• Analyze the risks and benefits of and indications for angioplasty and stenting.

Special Course 6 - Rat AnastamosisWorkshop The bus will depart from the Canal Street entrance of the SheratonNew Orleans Hotel at 7:30 AM. This course will take place at the LSUHealth Sciences Center, New Orleans.

Director: Saleem I. Abdulrauf, MDPanelists: Sepideh Amin-Hanjani, MD; John E. Wanebo, MD;Robert L. Macdonald, MD, PhD; Joel D. MacDonald, MD;Jacques J. Morcos, MD, FRCS; David J. Langer, MD; Peter A. Rasmussen, MD

This special course will include hands-on microvascular anastamosis training sessions on rat vessels. Illustrativevideo of actual extra-cranial to intra-cranial bypass procedures will be shown with discussion regarding indications and techniques.


• Examine microvascular anastamosis on rat vessels.

• Discuss indications of extracranial to intracranial by-pass procedures.

Special Course 7- Percutaneous SpineInterventionMAUREPAS – Third Floor

Co-Directors: John C. Steck, MD; Mary E. Jensen, MDPanelists: Allan L. Brook, MD; Kieran Murphy, MD, FRCS; James M. Milburn, MD, Joshua Hirsch, MD; Av e ry J. Evans, MD

Course description and learning objectives are available at theregistration desk.

6:00 - 7:30 PM

Opening ReceptionARMSTRONG BALLROOM – Eighth Floor

Come and enjoy a wonderful assortment of food and beverages as you visit with old friends and meet new colleagues at this years Opening Reception. The event will be held at the Sheraton New Orleans Hotel. All registered attendees will receive ONE complimentaryticket to the Opening Reception. Additional tickets are available for $65 each.

18

DAY TWO SCIENTIFIC SESSIONS

7:00 AM – 6:00 PM

Registration

GRAND BALLROOM FOYER – Fifth Floor

7:00 AM – 6:00 PM


7:00 – 7:45 AM

Continental Breakfast


7:45 - 8:00 AM

WelcomeFrank Culicchia, MD; John D. Barr, MD

GRAND BALLROOM ABC – Fifth Floor

8:00 - 10:00 AM

Scientific Symposium I - UnrupturedAneurysmsGRAND BALLROOM ABC – Fifth Floor

Moderators: Frank Culicchia, MD; John D. Barr, MD

Decision Making Analysis Surgical PerspectiveRobert E. Harbaugh, MD, FACS

Genetics of AneurysmsMurat Gunel, MD

Who Should Be Screened for AneurysmsJoseph Broderick, MD

New ISUIA DataDavid O. Wiebers, MD

New ISAT DataRichard Kerr, MD

Whether and how to treat unruptured intracranial aneurysmsremains controversial. This scientific session will help theparticipant to develop an understanding of the managementstrategies for treatment of unruptured intracranialaneurysms.

Learning Objectives: Upon completion of this ScientificSession, participants should be able to:

• Discuss the critical aspects of aneurysm treatment fromboth the endovascular and microsurgical perspective.

• Analyze and discuss the conclusions of the ISUIA studyand recognize the limitations of the study.

• Analyze and discuss the conclusions of the ISAT studyand recognize the limitations of the study.

• Identify factors of importance in deciding whether andhow to treat an unruptured intracranial aneurysm.

9:00 AM - 7:00 PM

Exhibits

NAPOLEON EXPOSITION HALL – Third Floor

10:00 - 10:30 AM

Beverage Break and Poster Viewing in the Exhibit Hall


10:30 - Noon

Oral Presentation Room AM o d e r a t o r s : Colin P. Derdeyn, MD; B. Gregory Thompson, Jr., MD


10:30 - 10:37 AM1. Aneurysm Screening After Surgical Treatment for

Ruptured Aneurysms (ASTRA) Marieke J. Wermer, MD; Irene van der Schaaf, MD (Utrecht, The Netherlands); on behalf of the ASTRA study group

10:38 - 10:45 AM2. Magnesium Sulfate in Aneurysmal Subarachnoid

Hemorrhage: A Randomized Controlled TrialWalter van den Bergh, MD (Utrecht, The Netherlands); MASH study group

10:46 - 10:53 AM3. Is Progressive Carotid Atherosclerosis a Risk Factor for

Ischemic Stroke: The Atherosclerosis Risk Factors inCommunities StudyM. Fareed K. Suri, MD; Adnan I. Qureshi, MD (Newark, NJ)

10:54 - 11:01 AM4. Intraoperative Neurophysiological Monitoring in 500

Carotid EndarterectomiesSvatopluk Ostry, MD; Lubor Stejskal, MD, PhD; Milan Mohapl,MD; Filip Kramar, MD; Bohumil Limberk, MD; Vladimir Benes,MD, PhD (Prague, Czech Republic)

11:02 - 11:09 AM5. Carotid Endarterectomy: 1000 Surgeries

Vladimir Benes, MD, PhD; Milan Mohapl, MD; David Netuka,MD; Filip Kramar, MD (Prague, Czech Republic)

11:10 - 11:17 AM6. Carotid Artery Stenting Without Protection Device:

Results With Diffusion-Weighted MRIA. Waaijer, MD; T.H. Lo, MD; G.A.P. de Kort, MD; Th. D Witkamp,MD; M. Prokop, MD, Prof (Utrecht, The Netherlands)

19

11:18 - 11:25 AM7. Comparison of In-Hospital Outcomes and Cost Incurred

Between Endovascular and Surgical Approachesfor Unruptured Intracranial AneurysmsAdnan I. Qureshi, MD; Abu Nasar, MS; Jawad F. Kirmani, MD; AfshinA. Divani, PhD; Ammar AlKawi, MD; Nazli A. Janjua, MD (Newark, NJ)

11:26 - 11:33 AM8. Systematic Review of Carotid Angioplasty With Stent

Placement for Treatment of High Surgical Risk Patients With Carotid StenosisShafiuddin Ahmed, MD; Jawad F. Kirmani, MD; Ammar Alkawi, MD;Nazli Janjua, MD; Afshin Divani, MD; Adnan I. Qureshi, MD (Newark, NJ)

11:34 - 11:41 AM9. Analysis of Patients With "Hyperdense Artery Sign" in the

National Institute Neurological Diseases and Stroke TissuePlasminogen TrialAdnan I. Qureshi, MD; Abu Nasar, MS; Jawad F. Kirmani, MD;Shafiuddin Ahmed, MD; Pansy Harris-Lane, NP; Afshin A. Divani, PhD(Newark, NJ)

11:42 - 11:49 AM10.Treatment, Outcomes, and Complications in 618

Consecutively Treated Middle Cerebral Artery AneurysmsThomas J. Altstadt, MD; Terry G. Horner, MD; Thomas Leipzig, MD;Troy Payner, MD; Kathy Redelman, RN, CNRN (Indianapolis, IN)

Oral Presentation Room BModerators: Jacques E. Dion, MD; Joshua B. Bederson, MD


10:30 - 10:37 AM11. Risk of Haemorrhage After Gamma Knife Treatment of Dural

Arteriovenous ShuntsTommy Andersson, MD, PhD; Jörgen Boethius, MD, PhD; BengtKarlsson, MD, PhD; Michael Söderman, MD, PhD (Stockholm,Sweden)

10:38 - 10:45 AM12. Accuracy of Digital Subtraction Angiography Used for

Symptomatic Carotid Stenosis Detection: AHistopathological StudyDavid Netuka, MD; Vladimir Benes, MD, PhD; Vaclav Mandys, MD,PhD; Jana Zvarova, MD, PhD; Jana Hlasenska, BA; Milan Mohapl,MD; Filip Kramar, MD (Prague, Czech Republic)

10:46 - 10:53 AM13. Hemorrhage Rate in Patients With Spetzler-Martin Grade IV

and V AVMs: Is Treatment Justified?Mahesh V. Jayaraman, MD; Mary L. Marcellus, RN; Huy M. Do, MD;Steven D. Chang, MD, PhD; Gary K. Steinberg, MD, PhD; Michael P.Marks, MD (Stanford, CA)

10:54 - 11:01 AM14. Trends in Cost and Outcome of Hospitalization for Stroke

and Stroke Subtypes in the United States Over the LastDecadeAdnan I. Qureshi, MD; Abu Nasar, MS; M. Fareed K. Suri, MD; JawadF. Kirmani, MD; Shafiuddin A. Ahmed, MD (Newark, NJ)

11:02 - 11:09 AM15. Neuroform Stent Supported Aneurysm Embolization:

Intermediate Term (3-6 Month) Follow-Up ResultsDavid Fiorella, MD (Cleveland, OH); Felipe C. Albuquerque, MD;Cameron G. McDougall, MD (Phoenix, AZ)

11:10 - 11:17 AM16. Matrix Coils for Intracranial Aneurysm Treatment: Early

Experience in a Single CenterYasunari Niimi, MD, PhD; Joon K. Song, MD; Alex Berenstein, MD(New York, NY)

11:18 - 11:25 AM17. Why do Unruptured Aneurysm and Good Grade (Hunt and

Hess Grades 1-2) Subarachnoid Hemorrhage Patients Die?Brian L. Hoh, MD; Bob S. Carter, MD, PhD; Christopher S. Ogilvy, MD(Boston, MA)

11:26 - 11:33 AM18. Anti-Inflammatory Treatment Enhances Neurogenesis

Following StrokeBenjamin D. Hoehn, BA; Theo D. Palmer, PhD; Gary K. Steinberg, MD,PhD (Stanford, CA)

11:34 - 11:41 AM19. Excimer Laser-Assisted High-Flow Bypass Surgery for the

Treatment of Complex Aneurysms and TumorsPeter Vajkoczy, MD; Thomas Kinfe, MD; Johannes Woitzik, MD; Peter Schmiedek, MD (Mannheim, Germany)

11:42 - 11:49 AM20. Outcome of Surgical Clipping of Unruptured Aneurysms as it

Compares to a 10-Year Nonclipping Survival PeriodAli F. Krisht, MD, FACS; Jorge Gomez, MD; Sharon Farrow, RN (Little Rock, AR)

20


Noon - 2:00 PM

Luncheon Seminars(Advanced registration is required for all Luncheon Seminars.)

01 Considerations for Planning and Purchase forNeuroangiography Systems

BAYSIDE A – Fourth Floor

Moderator: Robert C. Dawson III, MDPanelists: John D. Barr, MD; Yuichi Murayama, MD; JacquesE. Dion, MD; Felipe C. Albuquerque, MD

The participant will review the requirements of a modern neu-roangiography suite not only as it pertains to the room, butalso location with a hospital and personnel involved in dailyuse. The major equipment available for the suite will be criti-cally analyzed for use and efficiency. The participant should beable to develop a plan to begin the design of a modern neu-roangiography suite.

Learning Objectives: Upon completion of this seminar,participants should be able to:

• Discuss the requirements of a modern neuroangiographysuite in current practice and what will be necessary in thefuture.

• Critically assess available equipment and room configurations.

• Develop a plan to implement the information obtainedinto a suite that improves patient care, efficiency of the operator, and maximizes financial investment.

02 Management of Acute Cerebral Ischemia

OAK ALLEY – Fourth Floor

Moderator: John C. Chaloupka, MDPanelists: Daryl R. Gress, MD; Pierre Gobin, MD; Joshua B. Bederson, MD

This seminar is designed to explore surgical and endovascularoptions for sudden extracranial and intracranial vascular compromise.


• Identify acute ischemia.

• Discuss the limits of medical treatment.

• Identify patients who require surgery and thosewho are best treated with catheter techniques.

03 Management of Cortical AVM

NOTTOWAY – Fourth Floor

Moderator: Charles W. Kerber, MDPanelists: Philip E. Stieg, PhD, MD; H. Hunt Batjer, MD,FACS; John Pile-Spellman, MD

Risk stratification, emobilization methods and treatment management of AVM's will be discussed.


• Discuss the factors that modify the natural history.

• Discuss the factors that alter embolization and surgical risk.

• Identify and construct strategies for collaborative management of AVMs.

04 Management of the Poor Grade Aneurysm Patient

GRAND COUTEAU – Fifth Floor

Moderator: Jacques J. Morcos, MD, FRCSPanelists: Fernando Vinuela, MD; Randall T. Higashida, MD; Joseph M. Zabramski, MD; Bohdan W. Chopko, MD, PhD

This course will explore the latest surgical and endovascularapproaches and strategies in managing the patients withsevere aneurismal subarachnoid hemorrhage.


• Differentiate factors contributing to a poor grade.

• Formulate a scheme of treatment in most situations.

• Evaluate and contrast available treatment methods.

• Identify recommendations for endovascular treatment withangioplasty.

• Recognize patients with reduced cerebral blood flow.

05 Management of Deep and Brainstem AVMs

GRAND CHENIER – Fifth Floor

Moderator: Gary K. Steinberg, MD, PhDPanelists: Vance E. Watson, MD; Robert A. Mericle, MD; Michael P. Marks, MD

This seminar will address the multidisciplinary management of deep AVMs, including those located in the brainstem, cerebella nuclei, basal ganglia, thalamus, internal capsule andhypothalamas.


• Discuss indication for treatment of deep AVMs.

• Analyze the relative risks and benefits of emobilization, microsurgery and stereotactic radiosurgery.

• Review the natural history of the deep AVMs.

06 Surgical and Endovascular Cerebral Revascularization

BAYSIDE B & C – Fourth Floor

Moderator: Gary M. Nesbit, MDPanelists: Saleem I. Abdulrauf, MD; C. Michael Cawley, MD;Carlos A. David, MD; Gary Duckwiler, MD

This seminar will update the current status of carotid endarterec-tomy versus carotid stenting, and the current techniques andmaterials used in angioplasty/stenting. Surgical revascularizationtechniques and outcomes in acute ischemia will also be described.


• Document range of services rendered.

• Discuss the implications regarding diagnosis and time-basedservice.

• Discuss the use of alternative surgical revascularization techniques.

• Review current endovascular devices for cervical revascularization.

07Management of Dural AVMs

CORNET – Eighth Floor

Moderator: Steven D. Chang, MDPanelists: Issam A. Awad, MD; Michael J. Link, MD; Robert J. Coffey, MD

This seminar will discuss the natural history of dural AVMs, withemphasis on the differences between aggressive and benign. Thevarious therapeutic options, including surgery and endovasculartherapy, will be discussed.


• Differentiate benign from aggressive dural AVMs.

• Discuss the indications and techniques for surgical andendovascular therapy of dural AVMs.

08 Tools in Intracerebral Hemorrhage Diagnosis andManagement

SOUTHDOWN – Fourth Floor

Moderator: Alexander David Mendelow, PhDPanelists: Harold J. Pikus, MD; William Powers, MD; J. Claude Hemphill III, MD,

Acute intracerebral hemorrhage presents many challenges withregard to surgical and medical management. This seminar willfocus on evidence, consensus, and potential new therapies forintracerebral hemorrhage.


• Discuss treatment options and patient selection in management of intracerebral hemorrhage hematomas.

• Discuss current guidelines for critical care management.

• Describe at least two potential new treatment approaches forintracerebral hemorrhage.

09 Management Options in Occlusive Cervical CarotidDisease

SALON 817/821 – Eighth Floor

Moderator: B. Gregory Thompson, Jr., MDPanelists: Ian B. Ross, MD; Colin P. Derdeyn, MD; Sanat Dixit, MD; Joan C. Wojak, MD

This seminar will discuss current classification diagnosis andmanagement of intracranial occlusive disease. Surgical andendovascular treatment of lesions of the intracranial vasculaturewill be discussed.


• Define common lesions of the intracranial vasculature.

• Analyze treatment options for these lesions.

• Discuss the role of surgical and endovascular techniques.

10 Practical Considerations in Ruptured Anterior andPosterior Intracranial Aneurysms

SALON 816/820 – Eighth Floor

Moderator: Peter David LeRoux, MDPanelists: Peter Kim Nelson, MD; Arthur L. Day, MD, FACS; Bob S. Carter, MD, PhD; Tim Malisch, MD

This seminar will be an overview of the indications and contraindications for the treatment of ruptured intracranialaneurysms (UIA). Surgical and endovascular techniques will bediscussed, with a focus on the strengths and limitations of each,as well as, the results (safety, durability, etc.) of each treatmenttype.

21



• Discuss the indications for treatment of UIAs.

• Critically assess data emerging from recent studies.

• Discuss strengths and limitations of surgical and endovascular treatments.

2:10 - 2:25 PM

ASITN Presidential AddressGary Duckwiler, MD, to be introduced by John D. Barr, MD


2:25 - 2:40 PM

AANS/CNS Cerebrovascular SectionPresidential AddressPhilip E. Stieg, MD, PhD, to be introduced by Robert H.Rosenwasser, MD, FACS, FA


2:40 - 4:10 PM

Scientific Symposium II - Carotid DiseaseGRAND BALLROOM ABC – Fifth Floor

Moderators: Robert H. Rosenwasser, MD, FACS, FA; Gary Duckwiler, MD

Anti-Platelet Therapy in Neuroendovascular Intervention:Carotid DiseaseDavid Fiorella, MD

Sapphire Trial, Archer, Beach Trial UpdateGary M. Nesbit, MD

Data for Protection Devices are NecessaryAlex Abou-Chebl, MD

Volume Analysis and OutcomeLee R. Guterman, PhD, MD

Neuropsychological Evaluation Following TreatmentE. Sander Connolly, Jr., MD

Review of Current Studies that have Not Been PublishedColin P. Derdeyn, MD

Optimal management of patients with carotid artery stenosisis challenging, particularly for patients with asymptomaticdisease. The recent FDA approval of stents for treatment ofcarotid artery stenosis has added to the complexity of thetreatment algorithm. This scientific session will help the participant to develop an understanding of the managementstrategies for treatment of cervical carotid artery stenosis.

Learning Objectives: Upon completion of this scientific symposium, participants should be able to:

• Identify factors of importance in deciding how to treatcarotid artery stenosis.

• Discuss the critical aspects of carotid artery surgery fromboth the endovascular and surgical perspective.

• Analyze and discuss the conclusions of the studies thatled to FDA approval of carotid artery stents and recognizethe limitations of these studies.

• Discuss the conclusions of the major trials involvingpatients with asymptomatic carotid artery stenosis.

4:10 – 4:40 PM



4:40 - 6:10 PM

Oral Presentation Room AModerators: Tim Malisch, MD; TBD


4:40 - 4:47 PM21. Morphometric High-Resolution 3-D Analysis of

Intracranial Parent Vessel Remodeling Induced by theNeuroform StentDaniel Hoit, MD; Adel M. Malek, MD, PhD (Boston, MA)

4:48 - 4:55 PM22. Decision Making in the Diagnosis and Treatment of

Cerebral and Spinal Arteriovenous MalformationsVivian Hernandez-Burgos, MD; Veronica Hernandez-Burgos,MD; Waltter Kravcio, MD; Rafael Rodriguez-Mercado, MD, FACS(San Juan, PR)

4:56 - 5:03 PM23. Cost and Outcomes of Thrombolysis in the United

States: Data from the Nationwide Inpatient Survey2000-2001Nazli A. Janjua, MD; Abu Nasar, MS; Shafiuddin Ahmed, MD;Ammar Alkawi, MD; Ismail Khatri, MD; Adnan I. Qureshi, MD(Newark, NJ)

5:04 - 5:11 PM24. Distal Occlusion and Reocclusion in Combined

Intra-Arterial Protocol of Pharmacological andMechanical Thrombolysis: An Analysis of ThreeProspective Studies Nazli Janjua, MD; Ammar AlKawi, MD; Adnan I. Qureshi, MD;Jawad F. Kirmani, MD; Pansy Harris-Lane, CCRN; Afshin A.Divani, PhD; Shafiuddin Ahmed, MD (Newark, NJ); L. Hopkins, MD (Buffalo, NY)

22

5:12 - 5:19 PM25. Eyebrow Microcraniotomy for Acute Aneurysmal

Subarachnoid Haemorrhage: Results of 50 CasesHoward L. Brydon, MD, FRCS; Jazmeet Dhir, MB, BS, FRCS; AnwenHarries, MB, BS, FRCS; Ahmed Taha, MB, BS, FRCS; Said Kabir,MBChB, FRCS (Stoke-on-Trent, United Kingdom)

5:20 - 5:27 PM26. Novel Observations Regarding Acute Vasospasm and

Influence of Race on Outcome After SubarachnoidHemorrhageR. Loch Macdonald, MD, PhD; Axel Rosengart, MD (Chicago, IL)

5:28 - 5:35 PM27. Patterns of Cerebral Hemodynamic Impairment and Risk for

Infarct Evolution in Patients With Symptomatic VasospasmAfter Aneurysmal SAH: Brain Perfusion CT StudyGill E. Sviri, MD (Haifa, Israel); Ali H. Mesiwala, MD; Wendy Choen,MD; Gavin W. Britz, MD, MPH; Arthur Lam, MD; David W. Newell, MD(Seattle, WA)

5:36 - 5:43 PM28. Clazosentan, a Novel Selective Endothelin A Receptor

Antagonist, Prevents Cerebral Vasospasm FollowingAneurysmal SAHPeter Vajkoczy, MD (Mannheim, Germany); Bernhard Meyer, MD(Bonn, Germany); Stefan Weidauer, MD; Andreas Raabe, MD(Frankfurt, Germany); Claudius Thome, MD (Mannheim, Germany);Florian Ringel, MD (Bonn, Germany); Volker Breu, PhD (Allschwil,Switzerland); Peter Schmiedek, MD (Mannheim, Germany)

5:44 - 5:51 PM29. No Change in the Diameters of Vasospastic Intracranial

Arteries by Intra-Arterial Verapamil AdministrationAvi Mazumdar, MD; Dennis Rivet, MD; Christopher J. Moran, MD;DeWitte T. Cross, MD; Colin P. Derdeyn, MD (St. Louis, MO)

5:52 - 5:59 PM30. Methodology for Phase III Clinical Trial Planning: Powering

Treatment Studies of Vasospasm in SubarachnoidHemorrhageR. Loch Macdonald, MD, PhD (Chicago, IL); Kurt Kreiter, PhD; StephanM a y e r, MD (New York, NY); Volker Knappertz, MD (Chicago, IL)

Oral Presentation Room BModerators: Peter David Le Roux, MD; TBD

GRAND BALLROOM DE – Fifth Floor

4:40 - 4:47 PM31. Clinical and Angiographic Outcomes of Coil Embolization of

Posterior Communicating Artery AneurysmsAntonio Fernandes, MD; Lei Feng, MD, PhD; Ali Golshan, BS; GaryDuckwiler, MD; Reza Jahan, MD; Fernando Vinuela, MD (Los Angeles, CA)

4:48 - 4:55 PM32. Ruptured Versus Unruptured Aneurysms: An Analysis of

Age, Size, Location, Morphology, and HemodynamicFactorsCarlos A. David, MD; Vasilos Zerris, MD; In Sup Choi, MD(Burlington, MA)

4:56 - 5:03 PM33. Dynamic Perfusion CT in Cerebral Vasospasm Following

Aneurysmal SAH: A Comparative Study With 99mTc ECD-SPECT ImagingGill E. Sviri, MD, MSc (Haifa, Israel); Ali H. Mesiwala, MD; David H.Lewis, MD; Gavin W. Britz, MD, MPH; Arthur Lam, MD; WendyChoen, MD; David W. Newell, MD (Seattle, WA)

5:04 - 5:11 PM34. Psychosocial Impact of Screening for Intracranial

Aneurysms in Relatives with Familial SAHMarieke Wermer, MD; Pieter van Nunen, MSc; Irene van der Schaaf,MD; Gabriel Rinkel, MD, Prof (Utrecht, The Netherlands)

35. Withdrawn

5:20 - 5:27 PM36. Long-Term Outcome of STA-MCA Bypass in Moyamoya

Disease in North AmericaAli H. Mesiwala, MD (Los Angeles, CA); Gill E. Sviri, MD; David W.Newell, MD (Seattle, WA)

5:28 - 5:35 PM37. A Retrospective Regional Population Study of the Prevalence

and Appropriateness of Intravenous Heparin use forIschemic Stroke in Hispanics and African Americans in anUrban Hospital CommunityShafiuddin Ahmed, MD; Jawad F. Kirmani, MD; Ammar Alkawi, MD; F. A. Syed, MD; Amir Siddiqui, MD; Susan Szapiel, MD; P. Jethwa,BS; Afshin Divani, PhD; Haitham M. Nabil, MD; Abu I. Nasar, MS;Frederick Weisbrot, MD; Adnan I. Qureshi, MD, (Newark, NJ)

38. Withdrawn

5:44 - 5:51 PM39. Neurovascular Intervention Under Real-Time MRI Guidance

Lei Feng, MD, PhD; Erwin Lin, MD; Stephen Dashnaw; Hui Zhang,MS; Gaurav Gupta, MD; Rahmi Oklu, MD, PhD; Michael Baytion, DO;Tom Kim, BA; John Pile-Spellman, MD (New York, NY)

5:52 - 5:59 PM40. Endovascular Treatment of Brain AVMs Using Onyx:

Preliminary Results of a Prospective MulticenterStudyLaurent Pierot, MD, PhD (Reims, France); Anne-Christine Jahuel, MD(Toulouse, France); Denis Herbreteau, MD (Tours, France); XavierBarreau, MD (Bordeaux, France); Jacques Drouineau, MD (Poitiers,France); Anne Pasco-Papon, MD (Angers, France); Jerome Berge, MD(Bordeaux, France); Christophe Cognard, MD (Toulouse, France)

6:10 - 7:10 PM

Wine/Cheese Reception & Poster Viewing in the Exhibit Hall


Plan to attend the Wine and Cheese Reception in the Exhibit Hall.During the reception, you will have the opportunity to view the latest advances in technology and view the scientific poster presentations that have been selected for display at the 2005 Joint Annual Meeting of the AANS/CNS Cerebrovascular S e c t i o nand the American Society of Interventional & TherapeuticNeuroradiology. Visit with colleagues and enjoy a beverageand light hors d'oeuvres prior to heading out for the evening.

23

DAY THREE SCIENTIFIC SESSIONS

6:00 AM – 2:30 PM

Registration


6:30 AM – 1:00 PM


7:00 - 9:00 AM

Breakfast Seminars(Advanced registration is required for all Breakfast Seminars)

11Management of Giant Intracranial Aneurysms

BAYSIDE A – Fourth Floor

Moderator: Winfield S. Fisher III, MDPanelists: Ali F. Krisht, MD; Michel E. Mawad, MD; Jay U.Howington, MD; Robert H. Rosenwasser, MD, FACS, FA

This seminar presents expert viewpoints on the managementof giant cranial aneurysms both microsurgical and endovas-cular techniques will be discussed.


• Identify the treatment options in dealing with giantaneurysms.

• Assess the potential risks and scientific complications ofeach option.

• Recognize the individual parameters, size, location, content, anatomy, and flow characteristics of eachaneurysm.

12 Clips and Coils NOT Clips versus Coils:Collaborative Practice

OAK ALLEY – Fourth Floor

Moderator: John D. Barr, MDPanelists: Jacques E. Dion, MD; Robert C. Dawson III, MD;Clarence B. Watridge, MD, FA C S


• Recognize the continuum of neurovascular managementand the advantage of a team approach.

• Define the current indication for endovascular versus surgical management of aneurysms.

• Apply the information presented to improve patient outcomes through collaborative practice.

13 Neurosurgical and Endovascular Volunteerism in Developing Countries

CORNET – Eighth Floor

Moderator: Robert J. Dempsey, MDPanelists: Paul H. Young, MD; David Jeck, MD; Michael R. Chicoine, MD; Murat Gunel, MD

In many areas around the world, people with neurologicaldisorders will die or become permanently disabled due to acritical lack of trained neurological specialists. This seminarwill focus on the opportunities currently available to travel tothese countries to “teach and treat.”


• Identify the volunteer opportunities available in international neurosurgery

• Name several sites where neurosurgical volunteer activities may take place.

• Summarize the steps required to initiate such a process

• Describe the benefits to the volunteer and to the site fromsuch activity.

14 Management of Intracranial Occlusive Disease:Surgical and Endovascular Options

NOTTOWAY – Fourth Floor

Moderator: Fady T. Charbel, MDPanelists: Neil A. Martin, MD; John C. Chaloupka, MD;Peter A. Rasmussen, MD

Didactic presentations on operative and endovascular indications, patient selection, diagnostic evaluation, endovascular and surgical treatment techniques and outcomes assessment will review crucial issues for neurosurgeons and interventional neuroradiologists treatingpatients with extracranial carotid artery disease. Cases will be presented for discussion. Attendees are encouraged tobring diagnostic studies for case presentations to the faculty.


• Describe the treatment indications, criteria for patientselection, use of diagnostic studies, treatment techniquesand means of outcomes assessment pertinent to neuro-surgeons and interventional neuroradiologists treatingpatients with carotid artery.

• Apply this information to their neurosurgical or interventional neuroradiological practice.

• Describe and discuss the techniques for performingcarotid endarterectomy and carotid angioplasty and stenting.

24

15 Surgical and Endovascular Coding for NeurovascularProcedures and Critical Care

GRAND COUTEAU – Fifth Floor

Moderator: Paul Joseph Camarata, MDPanelists: John A. Wilson, MD, FACS; Mary E. Jensen, MD; JoseSuarez, MD

This course will review documentation strategies for neurosurgicalprocedures and critical care, appropriate billing and compliancewith relevant regulations.


• Document range of services rendered.

• Discuss the implications regarding diagnosis and time-based service.

• Discuss the use of alternative surgical revascularization techniques.

• Review current endovascular devices for cervical revascularization.

16 Management of Spinal Vascular Lesions

GRAND CHENIER – Fifth Floor

Moderator: Robert W. Tarr, MDPanelists: Rafael J. Tamargo, MD; In Sup Choi, MD; Cameron G.McDougall, MD; Alex Alejandro Berenstein, MD

Classification, surgical and endovascular treatmentof spine and spinal cord vascular malformations.


• Appraise the different types of vascular malformations.

• Discuss the anatomy and pathophysiology of spinal cord lesions.

17Management of Cerebral Vasospasm

BAYSIDE B & C – Fourth Floor

Moderator: Robert L. MacDonald, MD, PhDPanelists: Harish N. Shownkeen, MD; Sean D. Lavine, MD; E. Sander Connolly, Jr., MD

This course provides a comprehensive review of cerebral vasospasminduced by aneurysmal subarachnoid hemorrhage. This will includeincidence, prevalence, diagnosis, medical management, endovascularmanagement and surgical management with an emphasis on evidence-based data.


• Discuss the incidence, diagnosis and outcomes of cerebralvasospasm.

• Analyze the role of medical management and endovascularmanagement for cerebral vasospasm.

• Discuss the risks, benefits and procedural techniques forangioplasty, as well as the new approaches to vasospasm andcurrent clinical trials.

Vendor Sponsored Breakfast Seminars by:• Boston Scientific Neurovascular• Cordis Neurovascular• Micro Vention, Inc.Please see hotel reader board for locations. Attendees will NOTreceive CME for attendance at these sessions.

9:00 - 11:00 AM

Scientific Symposium III - VascularMalformationsGRAND BALLROOM ABC – Fifth Floor

Moderators: Robert E. Harbaugh, MD, FACS; Cameron G. McDougall, MD

Point Counter Point on Observation is Appropriate Therapy for AV M sJay P. Mohr, MD

Point Counter Point on Stereotactic Radiosurgery Therapy isAppropriate Therapy for AVMBruce E. Pollock, MD

Point Counter Point on Surgery is Appropriate Therapy for Brain AVMsH. Hunt Batjer, MD, FACS

Endovascular Therapy for Brain AVMsMichel E. Mawad, MD

How Does the Natural History Change After Embolization?Phillip D. Purdy, MD

Incomplete Surgical Treatment - A Partially Treated VascularMalformation Staging RadiosurgeryJoseph M. Zabramski, MD

With numerous treatment modalities available, the question oftenarises “Which single or combination modality is best for treating vascular malformations?” Some vascular malformations may be better treated with observation alone. This symposium will addressthe treatment modalities available to the patient harboring a vascularmalformation allowing the attendees to develop a treatment paradigm.


• Discuss the treatment options available for patients with brainvascular malformations.

• Critically assess the data emerging from clinical studies inmanagement of brain vascular malformations.

• Identify the patient appropriate for treatment and compose a course of treatment for patients with brain vascular malformations.

9:00 AM - 2:00 PM

Exhibits


11:00 AM - 11:30 PM


NAPOLEON EXPOSITION HALL – Third Floor 25

DAY THREE SCIENTIFIC SESSIONS

11:30 AM - 1:00 PM

Oral Presentation Room AM o d e r a t o r s : Joshua Hirsch, MD; Harish N. Shownkeen, MD


11:30 - 11:37 AM41. Selective Disconnection of Cortical Venous Reflux as

Treatment for Cranial Dural Arteriovenous FistulasJ. Marc C. Van Dijk, MD, PhD (Leiden, The Netherlands); KarelG. TerBrugge, MD; Robert A. Willinsky, MD; M. Chris Wallace,MD, MSc (Toronto,ON Canada)

11:38 - 11:45 AM42. Stroke Risk Stratification in Symptomatic

Vertebrobasilar DiseaseSepideh Amin-Hanjani, MD; Xinjian Du, MD; Meide Zhao, PhD;Katherine W. Walsh, RN, MS, NP; Fady T. Charbel, MD (Chicago, IL)

11:46 - 11:53 AM43. Prospective Evaluation of Treatment of Acute

Hypertension in Patients With Intracerebral HemorrhageUsing American Heart Association GuidelinesAdnan I. Qureshi, MD; Pansy Harris-Lane, NP; Molly Jacob, NP;Jawad F. Kirmani, MD; Shafiuddin A. Ahmed, MD; Yasin Zada,MD; Afshin A. Divani, PhD (Newark, NJ)

11:54 - 12:01 PM44. CT Angiography Versus Digital Subtraction Cerebral

Angiography for the Evaluation of Intracranial AneurysmClips, Endovascular Coils, and StentsRonald A. Alberico, MD; Joseph C. Wehman, MD; Ahmed A b d e l -Halim, MD, DMSc; Leo Hopkins, MD; Lee R. Guterman, PhD, MD(Buffalo, NY)

12:02 - 12:09 PM45. A Randomized, Blinded Assessment of

Pharmacokinetics and Pharmacodynamics of Sirolimus-Eluting Stents in the Canine Cerebral CirculationElad I. Levy, MD; Ricardo A. Hanel, MD (Buffalo, NY); DarrenSherman, BS (Miami Lakes, FL); Fermin O. Tio, MD; Lynn Bailey,BS; Mark Cunningham, PhD (Southbridge, MA); Clark Williard,BS (Princeton, NJ); Gregory Kopia, PhD; John Dooley, PhD(Warren, NJ)

12:10 - 12:17 PM46. United States After ISUIA and ISAT: Have Practice

Patterns Changed?Dongwoo Chang, MD, FRCS(C) (Sacramento, CA)

12:18 - 12:25 PM47. Embolization of Intracranial Aneurysms with Hydrogel-

Coated Coils Versus Inert Platinum Coils: Effects onPacking Density, Coil Length and Quantity, ProcedurePerformance, and CostRon C. Gaba, MD; Sameer A. Ansari, MD, PhD; Soma Sinha Roy,MD; Franklin A. Marden, MD; Marlos A. G. Viana, PhD; Fady T.Charbel, MD; Sepideh Amin-Hanjani, MD; Tim W. Malisch, MD(Chicago, IL)

12:26 - 12:33 PM48. A Decision Analysis of the Management Options for

Unruptured Intracranial AneurysmsCian J. O'Kelly, MD; Thorsteinn Gunnarsson, MD; M. Christopher Wallace, MD, FRCS(C) (Toronto, ON Canada)

12:34 - 12:41 PM49. Improved Outcomes Using Polymer-Coated (Matrix)

Detachable Coils: Preliminary Single-Center Experienceof 168 CasesMichael J. Alexander, MD, FACS; Osama O. Zaidat, MD; MarshallTolbert, MD; Keyne Thomas, MD; Ashutosh Pradhan, MD(Durham, NC)

12:42 - 12:49 PM50. Clinical Outcome and Technical Feasibility of

Intracranial Aneurysm Therapy Using Neuroform Stent-Assisted Coil EmbolizationMichael J. Alexander, MD, FACS; Osama O. Zaidat, MD; Marshall Tolbert, MD (Durham, NC)

26

Oral Presentation Room BM o d e r a t o r s : Christopher C. Getch, MD; Gavin W. Britz, MD


11:30 - 11:37 AM51. Intra-Arterial Verapamil for Cerebral Vasospasm

Lei Feng, MD, PhD (Los Angeles, CA); Michael Schmidt, PhD; ErwinLin, MD; Stephan Mayer, MD; John Pile-Spellman, MD (New York,NY)

11:38 - 11:45 AM52. Meta-Analysis of Stent-Supported Angioplasty Versus

Angioplasty Alone in the Management of IntracranialIschemiaNakul Vakil, MSc (Stony Brook, NY); Robert A. Koenigsberg, DO(Philadelphia, PA)

11:46 - 11:53 AM53. Prevalence of Cardiac Sources of Embolism in Patients With

a Recent Transient Ischemic Event and/or StrokeAbutaher M. Yahia, MD (East Lansing, MI); Joon-shik Moon, MD;Jawad Kirmani, MD (UMDNJ-NJ Medical School, NJ); Anwar Khokar,MD (East Lansing, MI); Vickie Gordon, NP; Richard Fessler, MD(Detriot, MI)

11:54 - 12:01 PM54. Age-Dependent Revascularization Patterns in the Treatment

of Moyamoya DiseasePeter Horn, MD; Peter Vajkoczy, MD; Peter Schmiedek, MD(Mannheim, Germany)

12:02 - 12:09 PM55. Magnetic Resonance Imaging of Iron-Labeled Neural

Progenitor Cells After Transplantation in a Rat Stroke ModelRaphael Guzman, MD; Tonya Bliss, PhD; Joan M. Greve, PhD; Theo D.Palmer, PhD; Guo Hua Sun, MD; Michael Moseley, PhD; GarySteinberg, MD, PhD (Stanford, CA)

12:10 - 12:17 PM56. The Value of Multislice CT Angiography in Postoperative

Control of Clipped AneurysmsAmir R. Dehdashti, MD; Stefano Binaghi, MD; Antoine Uske, MD;Luca Regli, MD (Lausanne, Switzerland)

12:18 - 12:25 PM57. Comparative Evaluation of GDCs, Hydrocoils, and Matrix

Coils in a Terminal Bifurcation Canine Aneurysm ModelYasunari Niimi, MD, PhD; Yoshikazu Yoshino, MD; Joon K. Song, MD(New York, NY); Shinya Kohyama, MD (Tokyo, Japan); Michael Silane,MD; Alejandro Berenstein, MD (New York, NY)

12:26 - 12:33 PM58. Volume of Cerebral Infarction and Clinical Outcome at 90

Days: Analysis of 616 PatientsJawad F. Kirmani, MD; Afshin A. Divani, PhD (Newark, NJ)

12:34 - 12:41 PM59. Delayed Administration of Simvastatin Prevents Vasospasm

in a Rabbit Model of Subarachnoid HemorrhageGustavo Pradilla, MD; Quoc-Anh Thai, MD; Federico G. Legnani, MD;Siva P. Raman, BS; Alia Hdeib, BS; Matthew J. McGirt, MD; Rafael J.Tamargo, MD; Richard E. Clatterbuck, MD, PhD (Baltimore, MD)

12:34 - 12:49 PM60. Selection of Intracranial Aneurysms for Surgical Treatment

in the Endovascular EraGustavo D. Luzardo, MD; Ian B. Ross, MD (Jackson, MS)

27

1:15 PM

Buses will depart from the Canal Street entrance of the SheratonNew Orleans Hotel to the Ernest N. Morial Convention Center forJoint Programming with the American Stroke AssociationAnnual International Stroke Conference

2:00 – 3:30 PM

Surgical vs. Endovascular AneurysmTreatment: Which is the Real GoldStandard?Moderators: Gary M Nesbit, MD; Frank Culicchia, MD

What is the Risk of Hemorrhage and Incidental Aneurysm?Robert M. Friedlander, MDSurgical Clipping is the Gold StandardArthur L. Day, MDEndovascular Surgery is the New Gold StandardJohn D. Barr, MDCase Management with Films and DiscussionPanel

This session has been jointly organized by the American Stroke Association, AANS/CNS Cerebrovascular Section, and the American Society of Interventional and TherapeuticNeuroradiology.Optimal management of patients with cerebral aneurysmsremains controversial, although there is supportive data forboth surgical and endovascular therapy. Natural history data has also suggested that the risks of any treatment in someaneurysms and in certain patients may outweigh the natural history. This scientific session will help the participant to develop an understanding of the management strategies for treatment of patients with cerebral aneurysms.


• Identify factors of importance in deciding when and how to treat cerebral aneurysms.

• Analyze and discuss the conclusions of the major trials of natural history, surgical, and endovascular treatment of cerebral aneurysms.

• Discuss the effectiveness, risks and recent advances in the various surgical and endovascular treatment options.

3:30 – 4:00 PM

Break

4:00 – 5:30 PM

Stenting vs. Endarterectomy: Treatment ofCarotid Artery Occlusive DiseaseM o d e r a t o r : John D Barr, MD; E. Sander Connolly, Jr., MD

Natural History and Risk of Carotid Artery StenosisJ. J. Connors, III, MDEndarterectomy: Still the Gold Standard?Christopher M. Loftus, MD, FACSStenting: Becoming the Gold Standard?Gary Duckwiler, MDCase Management with Films and DiscussionPanel

This session has been jointly organized by the American Stroke Association, AANS/CNS Cerebrovascular Section, and the American Society of Interventional & TherapeuticNeuroradiology

The optimal management of patients with carotid arterystenosis has become increasing complex, particularly forpatients with asymptomatic disease. The recent FDA approvalof stents for treatment of carotid artery stenosis has added tothe controversy of the treatment algorithm. This scientific session will help the participant to develop an understanding of the management strategies for treatment of cervical carotidartery stenosis.


• Identify factors of importance in deciding how to treatcarotid artery stenosis.

• Discuss the critical aspects of carotid artery surgery fromboth the endovascular and surgical perspective.

• Discuss the conclusions of the studies that led to FDAapproval of carotid artery stents and recognize the limitations of these studies.

• Discuss the conclusions of the major trials involving patientswith asymptomatic carotid artery stenosis.

5:30 – 7:30 PM

Poster Session/Reception at ISC

JOINT PROGRAMMING WITH THE AMERICAN STROKE ASSOCIATIONANNUAL INTERNATIONAL STROKE CONFERENCE

28

DAY FOUR

7:00 – 11:00 AM

Registration


7:00 – 11:00 AM


7:00 – 8:00 AM

Continental Breakfast


8:00 - 9:40 AM

Scientific Symposium IV - Stroke IschemicGRAND BALLROOM ABC – Fifth Floor

M o d e r a t o r s : Pierre Gobin, MD; Henry H. Woo, MD

Hemicraniectomy - NEUROSURGEON - SurgicalManagement of Ischemic StrokeChristopher S. Ogilvy, MD

Intravenous Thrombolysis for the Treatment of AcuteIschemic StrokeLeon Weisberg, MD

Intraarterial Thrombolysis for the Treatment of AcuteIschemic StrokeGary M. Nesbit, MD

Role of Inflammation in Ischemia/Stroke RiskRobert M. Friedlander, MD

Is There an Interest for Use of EC/IC Bypass?Daniel L. Barrow, MD

An increasingly larger number of acute stroke treatments areavailable. The available surgical, medical and endovasculartreatment options will be discussed. This scientific sessionwill help the participant to develop an understanding of themanagement strategies for treatment of acute stroke.


• Discuss the critical aspects of acute stroke treatment fromthe surgical, medical and endovascular perspectives.

• Identify factors of importance in deciding how to treat apatient with an acute stroke.

• Analyze and discuss the risks and benefits of the various treatment options.

9:00 - 11:00 AM

Exhibits


9:40 - 10:10 AM

Luessenhop LectureDuke S. Samson, MD

A New Look at an Old Problem. ..ModernManagement of Very Large and Giant Intracrani alAneurysms

The availability of new diagnostic procedures, the rapid evolution of endovascular techniques and the refinement of cerebral revascularization together promise to markedlyimprove outcome measures in these traditionally difficultaneurysms.

Duke S. Samson, MD is professor and chairman of theDepartment of Neurosurgery at the University of TexasSouthwestern Medical Center. Dr. Samson holds the endowedtitles of Lois C.A. and Darwin E. Smith Distinguished Chair inNeurological Surgery and Kimberly-Clark Distinguished Chairin Mobility Research. A native of Odessa, Texas, Dr. Samsonreceived his bachelor’s degree from Stanford University.He received his medical degree from Washington UniversitySchool of Medicine. His internship in straight surgery was atDuke University Medical Center, and his neurological surgeryresidency was at University of Texas Southwestern MedicalSchool.

Postgraduate fellowships were abroad at the Centre Medico - Chirurgical Foch (University Hospital of Paris) andKatonsspital, University of Zurich. Dr. Samson served in the United States military at Clark Air Force Base Hospital,Republic of the Philippines, Western Pacific NeurologicalCenter, followed by Walter Reed Army Medical Center inWashington, D.C.

Dr. Samson’s areas of specialty include microvascular surgery, cerebrovascular disease, and cervical spondylosis.His research activities have included intracranial arteriovenousmalformation, cerebral ischemia, and subarachnoid hemorrhage.

Dr. Samson has published 75 articles on cerebrovascular neurosurgery in a wide array of neurological, neurology andgeneral medical journals. He is principal author of IntracranialAneurysm Surgery: Techniques (1990). He has written chapters in nearly 40 neurosurgery books, and publishedmore than 50 abstracts, as principal or co-author.

He is a member of national and regional organizations including the American Association of Neurological Surgeons,the Congress of Neurological Surgeons, Texas Medical

29

DAY FOUR

Association, and Dallas County Medical Society.10:10 – 10:40 AM



10:40 AM - Noon

Oral Presentation Room AModerators: Jacques J. Morcos, MD, FRCS; Robert W. Tarr, MD


10:40 - 10:47 AM61. The Cordis Enterprise Stent for Treatment of Wide-Neck

Aneurysms: Preliminary Clinical Study ResultsRandall T. Higashida, MD (San Francisco, CA)

10:48 - 10:55 AM62. Impact of Anatomic Characteristics in Surgical Clipping

of Anterior Communicating Artery AneurysmsNestor R. Gonzalez, MD; Mehdi Tashini, MD; John Frazee, MD;Neil A. Martin, MD (Los Angeles, CA)

10:56 - 11:03 AM63. Endovascular Management of Cerebral Aneurysms: Our

Experience in Liverpool, UK With Ruptured AneurysmsAjay K. Sinha, FRCS (Liverpool, United Kingdom)

11:04 - 11:11 AM64. Technical Feasibility, Safety, and Short-Term Outcome

of Slow Inflation Elective Undersized BalloonAngioplasty of Medically Refractory IntracranialSymptomatic StenosisFiras Al-Ali, MD (Kalamazoo, MI); Vickie Gordon, NP (Detroit,MI); Abutaher M. Yahia, MD (East Lansing, MI)

11:12 - 11:19 AM65. Therapeutic Strategies for Dural Arteriovenous Fistulas

Jacques Moret, DR; Marco A. Stefani, MD, PhD; Michel Piotin,DR; Laurent Spelle, DR; Charbel Moynayer, DR (Paris, France)

11:20 - 11:27 AM66. Comparison of MERCI Mortality to PROACT II MERCI

Wade S. Smith, MD, PhD (San Francisco, CA)

11:28 - 11:35 AM67. Vasospasm Probability Index: A Combination of TCD

Velocities, CBF, and Clinical Risk Factors to PredictCerebral Vasospasm After Aneurysmal SAHNestor R. Gonzalez, MD; Thomas Glenn, PhD; John Boscardin,PhD; Yuichi Murayama, MD; Fernando Vinuela, MD; Neil A.Martin, MD (Los Angeles, CA)

11:36 - 11:43 AM68. Expression of the Elastin Gene in Ruptured Intracranial

AneurysmsYnte M. Ruigrok, MD; Gabriël Rinkel, MD, Ph; Bart van der Zwan,MD, Ph (Utrecht, The Netherlands); Zsolt Urban, PhD (St Louis, MO); Cisca Wijmenga, PhD (Utrecht, The Netherlands)

11:44 - 11:51 AM69. Aneurysmal Surgery in the Presence of Angiographic

Vasospasm: An Outcome AssessmentNancy McLaughlin, MD; Michel W. Bojanowski, MD, FRCS(C)(Montreal, PQ Canada)

Poster Award Presentations

• Basic Science Poster• Cerebrovascular Poster• Interventional Poster

30

Oral Presentation Room BModerators: Felipe C. Albuquerque, MD; Howard A. Riina, MD


70. Withdrawn

10:40 - 10:47 AM71. Aneurysm Treatment Evaluation: Quality of Life Perceived

by PatientsVladimir Benes, MD, PhD; David Netuka, MD; Marek Preiss, PhD;Jana Koblihova, PhD; Jiri Klose, PhD; Frantisek Charvat, MD (Prague,Czech Republic)

72. Withdrawn

10:56 - 11:03 AM73. Operator Training and Variability in Recanalization Rates

Following Intra-Arterial ThrombolysisGregory A. Christoforidis, MD; Yousef Mohammad, MD; AndrewSlivka, MD; Hassel W. Slone, MD; Eric C. Bourkas, MD; Donald W.Chakeres, MD (Columbus, OH)

11:04 - 11:11 AM74. Endovascular Coiling of Intracranial Aneurysms: Important

Factors Related to the Rates and Outcomes of IncompleteOcclusionMax K. Kole, MD (Detroit, MI); Stephen P. Lownie, MD; David Pelz, MD (London, ON Canada)

11:12 - 11:19 AM75. Selective Endovascular Treatment of Asymptomatic

Intracranial Aneurysms: Preliminary Results of aProspective StudyLaurent Pierot, MD, PhD (Reims, France); Christophe Cognard, MD(Toulouse, France); Alessandra Biondi, MD; Jean-Noel Vallee, MD(Paris, France); Serge Bracard, MD (Nancy, France); Denis Herbreteau,MD (Tours, France); Georges Rodesch, MD (Suresnes, France)

11:20 - 11:27 AM76. Resection of Supratentorial Cavernous Malformations:

Control of Epileptic SeizuresDavid Netuka, MD; Vladimir Benes, MD, PhD; Petr Kozler, MD, PhD(Prague, Czech Republic)

11:28 - 11:35 AM77. Risks of Anticoagulation in Neuroendovascular Procedures:

Parameters for Activated Clotting TimeStacey C. Quintero, MD; Mohammad Ali Aziz-Sultan, MD; NilsMueller, MD; Eugene Fu, MD; Michael Vigoda, MD; Alois Zauner, MD(Miami, FL)

11:36 - 11:43 AM78. One-Year Follow-Up Data for a Prospective Single-Center

Analysis of the Safety and Effectiveness of Hydrogel-CoatedPlatinum Coils in the Treatment of Cerebral AneurysmsEric M. Deshaies, MD; Celso Agner, MD; Matthew Adamo, MD;Sandeep Bagla, MD; A. John Popp, MD; Alan S. Boulos, MD (Albany, NY)

11:44 - 11:51 AM79. Aneurysm Bypass Surgery: Analysis of a Series of 29

Patients. Decision Making, Results, and Lessons LearnedJacques J. Morcos, MD, FRCS; Sanjiv Bhatia, MD; Ali Sultan, MD;Andrew Jea, MD (Miami, FL)

11:52 - 11:59 AM80. Interobserver Variability in Grading of Brain Arteriovenous

Malformations Using the Spetzler-Martin SystemRose Du, MD, PhD; Christopher Dowd, MD; William L. Young, MD;Michael T. Lawton, MD (San Francisco, CA)

31

day one special courses - neurosurgery...day one special courses 7:00 am – 6:00 pm registration...

Documents